Condition: Stroke · Hemiplegia and/or Hemiparesis Following Stroke · Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Stroke ranks second among the leading causes of death worldwide and third among the causes of disability. In stroke patients, motor impairment typically affects facial movements and the upper and lower extremities unilaterally. Upper extremity involvement, in particular, negatively impacts patients' activities of daily living, such as eating and dressing. Various rehabilitation methods are used to improve the function of the paretic upper extremity in stroke patients. Action Observation Therapy and Virtual Reality are among the rehabilitation approaches currently used to support upper extremity rehabilitation. In our study, patients will be randomly divided into two groups: one group will receive conventional rehabilitation and Action Observation Therapy, while the other group will additionally receive Virtual Reality therapy. This study aims to investigate the contribution of Virtual Reality therapy, when added to conventional rehabilitation and Action Observation Therapy, to the recovery of the paretic upper extremity in patients with subacute stroke.
This description comes directly from the study's public registry record.
Seda Akbayrak, MD · +90 5312478829 · akbayrakseda@gmail.com
Fatma Nur Kesiktaş, Prof. Dr. · +90 5414557933 · nur.kesiktas@gmail.com
Always discuss trial participation with your own doctor first.
| Istanbul Physical Therapy and Rehabilitation Training and Research Hospital | Istanbul, Bahçelievler, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07299162